Cytomegalovirus

Jan 05, 2022

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Jun 26, 2020

The Increasing Global Burden of Cytomegalovirus Seroprevalence

Newsletter/Whitepaper